Clinical trial Recruiting at 1 site Interventional Ages 21 to 90

Combining brain stimulation with therapy to improve hand movement after stroke

Official title: tDCS During Contralaterally Controlled FES for Upper Extremity Hemiplegia

Run by MetroHealth Medical Center · NCT05866003 · Data updated 2026-11-12

This study is testing whether different types of brain stimulation combined with therapy can help stroke survivors improve their hand movement.

Quick facts

Study typeInterventional
Ages21 Years to 90 Years
SexAll
Enrollment63 (estimated)
SponsorMetroHealth Medical Center
Academic / other
Locations1 site (Cleveland, Ohio)
StatusRecruiting
StartedJuly 1, 2023
Main results expectedApril 2028
Study endsApril 2028
Registry record updatedSeptember 29, 2025
Trial IDNCT05866003 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 21 to 90 who have experienced a stroke 6 to 24 months prior and have specific functional capabilities.

Probably not a fit

Patients with severe cognitive impairments or those unable to follow commands may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of three different non-invasive brain stimulation protocols combined with occupational therapy for stroke survivors experiencing upper extremity hemiplegia. Participants will be randomly assigned to receive either conventional tDCS, unconventional tDCS, or sham tDCS alongside contralaterally controlled functional electrical stimulation (CCFES) during a 12-week treatment period. The study will include a 6-month follow-up to assess recovery outcomes. All participants, therapists, and assessors will be blinded to the treatment received to ensure unbiased results.

Why it matters

Potential benefit: If successful, this approach could significantly enhance recovery of hand movement in stroke survivors, improving their quality of life.

How similar studies have gone: This study represents a novel approach, as it is the first randomized clinical trial combining tDCS with CCFES for this purpose.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 21 and ≤ 90
2. ≥ 6 and ≤ 24 months since first clinical hemorrhagic or nonhemorrhagic stroke
3. Able to follow 3-stage command
4. Able to remember 2 of 3 items after 30 minutes
5. Full volitional elbow extension/flexion and hand opening/closing of unaffected limb
6. Adequate active movement of shoulder and elbow to position the paretic hand in the workspace for table-top task practice
7. Patient must be able to sit unassisted in an armless straight-back chair for the duration of the screening portion of the eligibility assessment
8. Medically stable
9. ≥ 10° finger and wrist extension
10. Skin intact on hemiparetic arm, hand and scalp
11. Muscle contraction can be elicited with Transcranial Magnetic Stimulation
12. Unilateral upper limb hemiparesis with finger extensor strength of ≤ grade 4/5 on the Medical Research Council (MRC) scale
13. Score of ≥1/14 and ≤ 11/14 on the hand section of the upper extremity Fugl-Meyer Assessment
14. While relaxed, surface NMES of finger extensors and thumb extensors and/or abductors produces a functional degree of hand opening without pain.

Exclusion Criteria:

1. Co-existing neurological condition other than prior stroke involving the hemiparetic upper limb (e.g., peripheral nerve injury, PD, SCI, TBI, MS).
2. Uncontrolled seizure disorder
3. Use of seizure lowering threshold medications and the discretion of the study physician
4. Cardiac pacemaker or other implanted electronic device
5. Pregnant
6. IM Botox injections in any UE muscle in the last 3 months
7. Insensate arm, forearm, or hand
8. Deficits in communication that interfere with reasonable study participation
9. Severely impaired cognition and communication
10. Uncompensated hemi-neglect (extinguishing to double simultaneous stimulation)
11. Severe shoulder or hand pain (unable to position hand in the workspace without pain)

Where it's running

  • MetroHealth Medical Center
    Cleveland, Ohio, United States
    Recruiting

Study contacts

  • Principal investigator: David A Cunningham, PhD — MetroHealth Medical Center and Case Western Reserve University
  • Study coordinator: Amy Friedl, MS,OTR/L
  • Email: strokeresearch@metrohealth.org
  • Phone: 216-957-3598

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.